8
Views
57
CrossRef citations to date
0
Altmetric
Original Article

Haemodynamic Effects of a Long-Acting Somatostatin Analogue in Patients with Liver Cirrhosis

, , &
Pages 919-925 | Received 01 Dec 1986, Accepted 06 Mar 1987, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Søren Møller & Flemming Bendtsen. (2015) Complications of cirrhosis. A 50 years flashback. Scandinavian Journal of Gastroenterology 50:6, pages 763-780.
Read now

Articles from other publishers (56)

Anne C. Travis & Joshua R. Korzenik. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 2470 2489 .
Luke Simon Olivera Yuhico, Vinod Gundu & Robert Lenox. (2012) Octreotide-induced asystolic events in an intensive care unit patient with gastrointestinal bleeding. Heart & Lung 41:6, pages e18-e20.
Crossref
Pablo Laje, Lori Halaby, N Scott Adzick & Charles A Stanley. (2010) Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatric Diabetes 11:2, pages 142-147.
Crossref
Eline Vanheule, Anja M. Geerts, Hendrik Reynaert, Hans Van Vlierberghe, Albert Geerts, Martine De Vos & Isabelle Colle. (2007) Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver International 28:1, pages 107-116.
Crossref
J. VLACHOGIANNAKOS, A. KOUGIOUMTZIAN, C. TRIANTOS, N. VIAZIS, S. SGOUROS, S. MANOLAKOPOULOS, A. SAVERIADIS, C. MARKOGLOU, T. ECONOMOPOULOS & D. G. KARAMANOLIS. (2007) Clinical trial: the effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices. Alimentary Pharmacology & Therapeutics 26:11-12, pages 1479-1487.
Crossref
Félix Junquera, Esteban Saperas, Sebastián Videla, Faust Feu, Jaime Vilaseca, José Ramón Armengol, Josep María Bordas, Josep María Piqué & Juan-Ramón Malagelada. (2007) Long-Term Efficacy of Octreotide in the Prevention of Recurrent Bleeding from Gastrointestinal Angiodysplasia. The American Journal of Gastroenterology 102:2, pages 254-260.
Crossref
Soon Koo Baik, Phil Ho Jeong, Sang Won Ji, Byung Su Yoo, Hyun Soo Kim, Dong Ki Lee, Sang Ok Kwon, Young Ju Kim, Joong Wha Park, Sei Jin Chang & Samuel S Lee. (2005) Acute Hemodynamic Effects of Octreotide and Terlipressin in Patients with Cirrhosis: A Randomized Comparison. The American Journal of Gastroenterology 100:3, pages 631-635.
Crossref
John A. Dilger, Edwin H. Rho, Florencia G. Que & Juraj Sprung. (2004) Octreotide-Induced Bradycardia and Heart Block During Surgical Resection of a Carcinoid Tumor. Anesthesia & Analgesia, pages 318-320.
Crossref
Y. Eroglu, K. M. Emerick, P. F. Whitingon & E. M. Alonso. (2004) Octreotide Therapy for Control of Acute Gastrointestinal Bleeding in Children. Journal of Pediatric Gastroenterology and Nutrition 38:1, pages 41-47.
Crossref
Lene Simonsen, Robert Coker, Nariman A. L. Mulla, Michael Kjær & Jens Bülow. (2008) The effect of insulin and glucagon on splanchnic oxygen consumption. Liver 22:6, pages 459-466.
Crossref
Peter Schiedermaier, Burkhard Göke & Tilman Sauerbruch. (2001) Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS. American Journal of Gastroenterology 96:7, pages 2218-2224.
Crossref
E. Matrella, V. Valatas, G. Notas, H. Roumpaki, C. Xidakis, A. Hadzidakis, I. Mouzas & E. Kouroumalis. (2002) Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO‐independent mechanism in chronic liver disease. Alimentary Pharmacology & Therapeutics 15:6, pages 857-864.
Crossref
Àngels Escorsell, Juan Carlos Bandi, Victòria Andreu, Eduardo Moitinho, Joan Carles Garcí-Pagán, Jaume Bosch & Joan Rodés. (2001) Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 120:1, pages 161-169.
Crossref
Marshall J. Orloff. 2001. Surgical Research. Surgical Research 637 701 .
Jaime Bosch & Juan Carlos García-Pagán. (2000) Complications of cirrhosis. I. Portal hypertension. Journal of Hepatology 32, pages 141-156.
Crossref
Han-Chieh Lin, Yi-Tsau Huang, Hann-Lung Wu, Wui-Chiang Lee, Ming-Chih Hou, Fa-Yauh Lee, Full-Young Chang & Shou-Dong Lee. (1999) Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis. Journal of Hepatology 31:3, pages 482-488.
Crossref
Han-Chieh Lin, Ming-Chih Hou, Wui-Chiang Lee, Yi-Tsau Huang, Fa-Yauh Lee, Full-Young Chang, Yang-Te Tsai & Shou-Dong Lee. (1999) Effects of Octreotide on Central Hemodynamics and Systemic Oxygen Use in Patients With Viral Cirrhosis. American Journal of Gastroenterology 94:4, pages 1012-1017.
Crossref
Gennaro D'Amico, Flavia Politi, Alberto Morabito, Adele D'Antoni, Daniela Guerrera, Gandolfo Giannuoli, Mario Traina, Giovanni Vizzini, Linda Pasta & Luigi Pagliaro. (1998) Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial. Hepatology 28:5, pages 1206-1214.
Crossref
Ottesen, Flyvbjerg, Møller & Bendtsen. (1998) The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients. Alimentary Pharmacology & Therapeutics 12:7, pages 657-665.
Crossref
Frédéric Oberti, Nary Veal, Mehdi Kaassis, Christophe Pilette, Hervé Rifflet, Renaud Trouvé & Paul Calès. (1998) Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. Journal of Hepatology 29:1, pages 103-111.
Crossref
Christian Mottet, Cornel C. Sieber, Andr� Nauer, J�rgen Drewe, Ronald Fried, Finn Larsen & Christoph Beglinger. (1998) Hemodynamic effects of the somatostatin analog lanreotide in humans: Placebo-controlled, cross-over dose-ranging echo-doppler study. Hepatology 27:4, pages 920-925.
Crossref
R. Moreau, S. Cailmail, A. Gadano, D. Valla & D. Lebrec. (1997) Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol. Alimentary Pharmacology and Therapeutics 11:4, pages 775-779.
Crossref
Søren Møller, Kim Brinch, Jens H. Henriksen & Ulrik Becker. (1997) Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis. Journal of Hepatology 26:5, pages 1026-1033.
Crossref
Lone Harild Ottesen, Allan Flyvbjerg, Preben Jakobsen & Flemming Bendtsen. (1997) The pharmacokinetics of octreotide in cirrhosis and in healthy man. Journal of Hepatology 26:5, pages 1018-1025.
Crossref
Alberto Malesci, Milena Tacconi, Angela Valentini, Mauro Basilico, Elettra Lorenzano & Francesco Salerno. (1997) Octreotide long-term treatment in patients with portal hypertension: persistent inhibition of postprandial glucagon response without major changes in renal function. Journal of Hepatology 26:4, pages 816-825.
Crossref
L. Y. CHAN & J. J. Y. SUNG. (1997) Review article: the role of pharmaco-therapy for acute variceal haemorrhage in the era of endoscopic haemostasis. Alimentary Pharmacology and Therapeutics 11:1, pages 45-50.
Crossref
G. Zironi, C. Rossi, S. Siringo, C. Galaverni, S. Gaiani, F. Piscaglia & L. Bolondi. (2008) Short‐ and long‐term hemodynamic response to octreotide in portal hypertensive patients: a double‐blind, controlled study. Liver 16:4, pages 225-234.
Crossref
F Nevens, W Van Steenbergen, S H Yap & J Fevery. (1996) Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide.. Gut 38:1, pages 129-134.
Crossref
Han-Chieh Lin, Yang-Te Tsai, May C.-M. Yang, Fa-Yauh Lee, Ming-Chih Hou, Ling-Sheng Chen & Shou-Dong Lee. (1996) Effect of octreotide on total effective vascular compliance in patients with posthepatitic cirrhosis. Journal of Hepatology 24:1, pages 81-87.
Crossref
Paolo Avagnina, Marco Martini, Massimo Terzolo, Gianni Sansoé, Paola Peretti, Marco Tinivella, Anna Pia, Gianpaolo Molino & Alberto Angeli. (1996) Assessment of functional liver mass and plasma flow in acromegaly before and after long-term treatment with octreotide. Metabolism 45:1, pages 109-113.
Crossref
Massimo Pkimignani, Bruno Andreoni, Luca Carpinelli, Alfonso Capria, Gabriele Rocchi, Ivano Lorenzini, Carlo Staudacher, Luigi Beretta, Roberta Motta & Roberto DeFranchis. (1995) Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial. Hepatology 21:5, pages 1322-1327.
Crossref
P. Aiden McCormick, Jason Chin, Lynda Greenslade, Stelios Karatapanis, Robert Dick, Neil McIntyre & Andrew K. Burroughs. (1995) Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 21:5, pages 1255-1260.
Crossref
Victor J. Navarro & Guadalupe Garcia-Tsao. (1995) Variceal Hemorrhage. Critical Care Clinics 11:2, pages 391-414.
Crossref
Naoki Hori, Takeshi Okanoue, Yoshihiko Sawa, Yoshito Itoh, Takashi Mori, Shiro Takami & Kei Kashima. (1994) Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats. Journal of Gastroenterology 29:4, pages 460-468.
Crossref
Han-Chieh Lin, Yang-Te Tsai, Cheng-Chun Huang, Hong-Chiang Meng, Fa-Yauh Lee, Sun-Sang Wang, Shou-Dong Lee & Kwang-Juei Lo. (1994) Effects of octreotide on postprandial systemic and hepatic hemodynamics in patients with postnecrotic cirrhosis. Journal of Hepatology 21:3, pages 424-429.
Crossref
Paul R. Tarnasky, Thomas O.G. Kovacs, Felix W. Leung, Ken Hirabayashi & Dennis M. Jensen. (1994) Octreotide decreases canine gastric mucosal blood flow: A controlled assessment by endoscopic reflectance spectrophotometry. Gastrointestinal Endoscopy 40:1, pages 56-61.
Crossref
Jens H. Henriksen & Helmer Ring-Larsen. (1993) Renal effects of drugs used in the treatment of portal hypertension. Hepatology 18:3, pages 688-695.
Crossref
Christine Silvain, Stéphane Carpentier, Denis Sautereau, Bella Czernichow, Jean-michel Métreau, Eric Fort, Pierre Ingrand, Jean Boyer, Bernard Pillegand, Michel Doffël, Daniel Dhumeaux & Michel Beauchan. (1993) Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial. Hepatology 18:1, pages 61-65.
Crossref
Naoki Hori, Takeshi Okanoue, Yoshihiko Sawa, Takashi Mori & Kei Kashima. (1993) Effect of a somatostatin analogue (SMS 201–995) on hemodynamics and glucagon secretion in cirrhotic rats. Gastroenterologia Japonica 28:2, pages 276-283.
Crossref
Lin Han-Chieh & Tsai Yang-Te. (1992) Reply. Gastroenterology 103:6, pages 1992-1993.
Crossref
P. Aiden McCormick, Maria Rosa Biagini, Robert Dick, Lynda Greenslade, Jason Chin, Fabrizio Cardin, Donald Wagstaff, Neil McIntyre & Andrew K. Burroughs. (1992) Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: A double-blind, placebo-controlled study. Hepatology 16:5, pages 1180-1186.
Crossref
K.E. Gyr & R. Meier. (1992) Pharmacodynamic effects of Sandostatin® in the gastrointestinal tract. Metabolism 41:9, pages 17-21.
Crossref
Han-Chieh Lin, Yang-Te Tsai, Fa-Yauh Lee, Shou-Dong Lee, Hsiao-Chung Hsia, Wen-Jeh Lin & Kwang-Juei Lo. (1992) Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 103:1, pages 229-234.
Crossref
. (1992) Octreotide steaming ahead. The Lancet 339:8797, pages 837-839.
Crossref
Federico Rodríguez-Pérez & Roberto J. Groszmann. (1992) PHARMACOLOGIC TREATMENT OF PORTAL HYPERTENSION. Gastroenterology Clinics of North America 21:1, pages 15-40.
Crossref
Bosch Jaime & Terés José. (1992) Immediate Management of Variceal Hemorrhage: Pharmacologic Measures and Balloon Tamponade. Gastrointestinal Endoscopy Clinics of North America 2:1, pages 43-58.
Crossref
Shinn-Jang Hwang, Han-Chieh Lin, Chia-Fu Chang, Fa-Yauh Lee, Chi-Wen Lu, Hsiao-Chung Hsia, Sun-Sang Wang, Shou-Dong Lee, Yang-Te Tsai & Kwang-Juei Lo. (1992) A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. Journal of Hepatology 16:3, pages 320-325.
Crossref
Alan G. Harris. (2012) Octreotide in the Treatment of Disorders of the Gastrointestinal System. Drug Investigation 4:S3, pages 1-54.
Crossref
René W.M.M. Jansen & Willibrord H.L. Hoefnagels. (1991) Hormonal Mechanisms of Postprandial Hypotension. Journal of the American Geriatrics Society 39:12, pages 1201-1207.
Crossref
Everett J. Mozell, Eugene A. Woltering & Thomas M. O'Dorisio. (1991) Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy. Disease-a-Month 37:12, pages 749-810.
Crossref
A.K. Burroughs. (1991) Somatostatin and octreotide for variceal bleeding. Journal of Hepatology 13:1, pages 1-4.
Crossref
M. Classen, W. Domschke, K.-U. Schentke, U. Kobe, M. Rössle, M. Sellinger & F. Hagenmüller. 1991. Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 263 278 .
JÜRg Reichen. (1990) Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 11:6, pages 1066-1078.
Crossref
Rene W. M. M. Jansen, Paul H. E. M. de Meijer, Henk J. J. van Lier & Willibrord H. L. Hoefnagels. (2015) Influence of Octreotide (SMS 201–995) and Insulin Administration on the Course of Blood Pressure After an Oral Glucose Load in Hypertensive Elderly Subjects. Journal of the American Geriatrics Society 37:12, pages 1135-1139.
Crossref
Jaime Bosch, Miquez Navasa, J.C. Garcia-Pagán, A.M. DeLacy & J. Rodés. (1989) Portal Hypertension. Medical Clinics of North America 73:4, pages 931-953.
Crossref
L. S. ERIKSSON & J. WAHREN. (2008) Intravenous and subcutaneous administration of a long‐acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects. European Journal of Clinical Investigation 19:2, pages 213-219.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.